Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.180
+0.030 (2.61%)
At close: May 12, 2025, 4:00 PM
1.270
+0.090 (7.63%)
After-hours: May 12, 2025, 7:53 PM EDT
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $76.18 million as of May 12, 2025. Its market cap has decreased by -71.97% in one year.
Market Cap
76.18M
Enterprise Value
9.97M
1-Year Change
-71.97%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $76.18M, a decrease of -78.62%. That is a compound annual growth rate of -27.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 74.25M | -58.28% |
| Dec 31, 2024 | 177.95M | -32.37% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |